Antigen specificity of clonally enriched CD8+ T cells in multiple sclerosis.

Saved in:
Bibliographic Details
Title: Antigen specificity of clonally enriched CD8+ T cells in multiple sclerosis.
Authors: Hayashi F; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Mittl K; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Dandekar R; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Gerdts J; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Hassan E; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Schubert RD; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Oshiro L; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Loudermilk R; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Greenfield A; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Augusto DG; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.; Department of Biological Sciences, The University of North Carolina at Charlotte, Charlotte, NC, USA., Havton G; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Anumarlu S; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.; University of California Berkeley, Berkeley, CA, USA., Surapaneni A; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.; University of California Los Angeles, Los Angeles, CA, USA., Ramesh A; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Tran E; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Koshal K; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Kizer K; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Dreux J; 3T Biosciences, South San Francisco, CA, USA., Cagalingan AK; 3T Biosciences, South San Francisco, CA, USA., Schustek F; 3T Biosciences, South San Francisco, CA, USA., Flood L; 3T Biosciences, South San Francisco, CA, USA., Moore T; 3T Biosciences, South San Francisco, CA, USA., Kirkemo LL; 3T Biosciences, South San Francisco, CA, USA., Fisher IJ; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Cooper T; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Harms M; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Gomez R; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Clelland CD; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Sibener L; 3T Biosciences, South San Francisco, CA, USA., Cree BAC; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Hauser SL; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Hollenbach JA; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA., Gee M; 3T Biosciences, South San Francisco, CA, USA., Wilson MR; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Zamvil SS; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA. zamvil@ucsf.neuroimmunol.org., Sabatino JJ Jr; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA. joseph.sabatinojr@ucsf.edu.
Corporate Authors: University of California, San Francisco MS-EPIC Team
Source: Nature immunology [Nat Immunol] 2026 Mar; Vol. 27 (3), pp. 490-502. Date of Electronic Publication: 2026 Feb 05.
Publication Type: Journal Article
Journal Info: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1529-2916
DOI:10.1038/s41590-025-02412-3